Indian biotechnology company and vaccine manufacturer
Bharat Biotech ▸ Facts ▸ Comments ▸ News ▸ Videos
BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 | Oneindia News
Credit: Oneindia Duration: 02:01Published
Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News
Credit: Oneindia Duration: 03:39Published
Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News
Credit: Oneindia Duration: 03:17Published
Chhattisgarh will receive 3.50 lakh doses of Covishield today
Credit: ANI Duration: 01:25Published
India receives first lot of Sputnik V vaccine
Credit: ANI Duration: 02:00Published
Have asked for 67 lakh doses each from both vaccine manufacturing companies: CM Kejriwal
Credit: ANI Duration: 01:50Published
Vaccine manufacturers will supply vaccine by May end: Jharkhand Health Minister
Credit: ANI Duration: 01:44Published
After SII, Bharat Biotech reduces Covaxin price; Rs 400 per dose for state govts
Credit: HT Digital Content Duration: 01:25Published
Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states
Credit: HT Digital Content Duration: 01:27Published
Phase-3 vaccination depends on availability of doses: Odisha govt
Credit: ANI Duration: 01:26Published
Centre asks Serum Institute, Bharat Biotech to lower Covid vaccines’ price
Credit: HT Digital Content Duration: 01:28Published
Assam govt to give free COVID vaccines to everyone from 18-45 years
Credit: ANI Duration: 01:40Published
You Might Like
Covaxin does not contain newborn calf serum, say Bharat Biotech and govt
Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirmThe final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said
Covaxin does not contain newborn calf serum: Centre busts mythsThe indigenously developed Covaxin does not contain newborn calf serum, clarified Centre on Wednesday. The statement came in response to some social media posts which the government said have "twisted..
SII, Bharat Biotech seek hike in government price for Covid vaccinesSerum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals..
Bharat Biotech says Rs 150 per Covaxin dose to government not sustainableThe vaccine maker has said that it had to invest over Rs 500 crore at risk from its resources for product development, clinical trials, manufacturing.
Covaxin average price realisation less than Rs 250 per dose: Bharat Biotech
CISF takes over security of Bharat Biotech plant
CISF takes over security of Covaxin manufacturer Bharat Biotech's Hyderabad campus
Covaxin maker Bharat Biotech gets CISF cover of 64 personnel
Can person with any allergy take COVID-19 shots? Know what experts sayBharat Biotech, the manufacturer of the COVID-19 vaccine said that those who have known allergies to any component of Covaxin should not take the jab.
Committed to data transparency on Covaxin, published 9 papers in 12 months: Bharat Biotech
Ocugen to seek emergency nod for Covaxin from Health CanadaBharat Biotech’s US partner Ocugen said it will be seeking an emergency use nod for India’s first indigenously developed Covid-19 vaccine Covaxin from the Canadian health authorities. The company..
Ocugen to seek full approval for Covaxin in US via BLA instead of EUABharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application..
Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for CanadaBharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application..
Brazil regulator grants GMP certification to Bharat Biotech's Covaxin facilitiesLess than a week after Brazil’s health regulator green-lighted the “exceptional import” of 4 million doses of Bharat Biotech’s Covid-19 jab Covaxin, it has now granted certification of Good..
Bharat Biotech to conduct Covaxin Phase-4 trials to check real-world effectiveness
Bharat Biotech exec, researcher spar over vaccine-efficacy study
Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
Good immune response from Covishield & Covaxin: StudyA ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients and prevent serious disease in those infected..
Brazil health regulator finally gives green signal for Covaxin importsIn a move that paves the way for exports of indigenously developed Covid-19 vaccine Covaxin to Brazil, its health regulator Anvisa (Agência Nacional de Vigilância Sanitária) has finally given the..
After US market, Bharat Biotech ties up with Ocugen for Covaxin sale in Canada
Covid-19: Government plans 1 crore daily vaccines from middle of JulyThe Centre plans to ramp up vaccination against Covid-19 on a “mission mode”, targeting an average of around 1 crore inoculations per day from around mid-July or August as vaccine supplies are..
Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by July-end: Dr NK AroraWith ramping up of production capacities, nearly 25 crore 'Made in India' vaccines are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the..
2.8 crore doses of Covaxin supplied so far, says CentreBharat Biotech has supplied almost 2.8 crore doses of Covaxin to the Centre as of May 28 morning, a PIB release said on Friday. Of these, about 2.2 crore doses, including wastage, have been consumed by..
Centre creating 'artificial scarcity' of Covid vaccines to benefit Bharat Biotech, SII: AAP
Covaxin puzzle: 6 crore shots ready, 2 crore given. Where are the rest?The mismatch between reported production numbers of Covid vaccines in India and the level of daily vaccination seems particularly acute in the case of Covaxin. Official data shows 2.1 crore doses of..
Bharat Biotech files 2 new GMP certification requests with Brazil's Anvisa for Covaxin
ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin
Covaxin reached 30 cities in 30 days, says Bharat Biotech's co-founder
Bharat Biotech likely to get a pre-qualification approval from WHO by AugustThe company has informed the government that it is currently in the process of submitting documents, particularly regarding validation of one of its manufacturing facilities. It is also..
Bharat Biotech needs to give more information for emergency use listing, says WHO
WHO says 'more information' required from Bharat Biotech for emergency use listing of Covaxin
Bharat Biotech submitted 90% of documentation to WHO for emergency use listing for Covaxin: Sources
Paediatric trials of Covaxin may begin in June: Bharat Biotech officialBharath Biotech may start clinical trials of its Covid-19 vaccine Covaxin on children from June, a senior official of the vaccine-maker has said. The efficacy of the jab can be improved up to 100%..
Also reported by •DNA
Bharat Biotech applies for WHO approval, pre-submission meeting soonIt will have to now go through 3 more stages--pre-submission meeting, dossier accepted for review and the final status of assessment.
Government steps in to expedite WHO approval for CovaxinToI has learnt that foreign secretary Harsh Shringla will hold a meeting with Bharat Biotech, the manufacturer of Covaxin, on Monday to expedite the process of WHO approval for the indigenously..
Exclusive: Bharat Biotech's Suchitra Ella confident on vaccine production commitmentsShe assured that Covaxin was proved to be neutralizing the double mutant variant found in India and other variants found abroad.
Bharat Biotech targets 1billion/year doses by 2021-end
Bharat Biotech to ramp up Covaxin production to 1 billion doses a yearHyderabad-based Bharat Biotech is planning to scale up the production capacity of its indigenously-developed Covid vaccine — Covaxin — to 1 billion doses per annum by the fourth quarter of 2021.A..
Covaxin trial for 2-18 yrs age group to begin in 10-12 days, govt saysTrial of Bharat Biotech's Covaxin in the 2-18 years age group is likely to begin in the next 10-12 days., a govt official said. The vaccine received DCGI approval for the trials last week. 1.8% of..
Covaxin effective against India, UK coronavirus strains: Bharat Biotech
Covaxin effectively neutralises all key emerging variants, says study published in Oxford journalIndigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first identified in India and the UK, its developer..
Get Bharat Biotech to share vaccine manufacturing tech with other WHO prequalified pharma cos: Ghulam Nabi Azad
Covaxin dispatched to various states like Gujarat, Assam: Bharat Biotech
Centre, Bharat Biotech willing to invite other companies to scale up Covaxin productionAmid the reports of coronavirus vaccine shortage from various states, the Central government and Hyderabad-based Bharat Biotech are willing to invite other companies which want to produce COVAXIN in a..
Bharat Biotech's 50 employees test COVID-19 positive, Joint MD's tweet evokes mixed response on TwitterSuchitra Ella's tweet evoked mixed response from netizens with some questioning the effectiveness while others asked why the staff was not vaccinated.
DGCI gives nod for Covaxin Phase II/III trials on 2-18 year oldsThe Indian drugs regulator, the Drugs Controller General of India (DCGI) has granted its approval to indigenously developed Covid-19 vaccine Covaxin’s developer Bharat Biotech for conducting Phase..
50 employees of Bharat Biotech test Covid-19 positive; Joint MD's tweet draws bouquets and brickbats
Serum says will raise monthly production to 10 crore doses by August, Bharat Biotech promises 7.8 crore
Covid-19: DCGI approves phase 2, 3 clinical trials of Covaxin on children aged 2 to 18 yearsThe Drugs Controller General of India (DCGI) approved phase 2 and 3 clinical trials of Bharat Biotech's Covaxin vaccine for the age group of 2 to 18 years, the ministry of health and family welfare..